ҽѧÃâ·ÑÂÛÎÄ:»ÆÜËÜÕ¶ÔÈËÑÀÖÜĤϸ°ûRANKL OPG±í´ïµÄÓ°Ïì¼°Æä×÷ÓûúÖÆ

¡¾²Î¿¼ÎÄÏס¿

[1]KANZAKI H, CHIBA M, SHIMIZU Y, et al. Dual regulation of osteoclast differentiation by periodontal ligament cells through RANKL stimulation and OPG inhibition [J]. J Dent Res, 2001, 80(3):887ª²891.

[2]HASEGAWA T, YOSHIMURA Y, KIKUIRI T, et al. Expression of receptor activator of NFª²kappa B ligand and osteoprotegerin in culture of human periodontal ligament cells [J]. J Periodontal Res, 2002, 37(6):405ª²411.

[3]ZHANG D, YANG YQ, LI XT, et al. The expression of osteoprotegerin and the receptor activator of nuclear factor kappa B ligand in human periodontal ligament cells cultured with and without 1alpha, 25ª²dihydroxyvitamin D3 [J]. Arch Oral Bio, 2004, 49(1):71ª²76Ò½.ѧ.È«.ÔÚ.Ïßwww.lindalemus.com.

[4]WANG GF, WU ZF, WAN L, et al. A study of the inhibitory effects of compound of icariin, emodin and baicalin on bone absorption in experimental periodontitis in rats [J]. J Clin Stomatol, 2005, 21(6):321ª²323.

[5]ROGGIA C, GAO Y, CENCI S, et al. Upª²regulation of TNFª²producing T cells in the bone marrow: a key mechanism by which estrogen deficiency induces bone loss in vivo [J]. Proc Natl Acad Sci USA, 2001, 98(24):13960ª²13965.

[6]BAKER PJ, HOWE L, GARNEAU J, et al. T cell knockout mice have diminished alveolar bone loss after oral infection with Porphyromonas gingivalis [J]. FEMS Immunol Med Microbiol, 2002, 34(1):45ª²50.

[7]YU Y, YANG YJ, TAO YG. Effect of baicalin and dexamethasone on cytokines in brain tissue of infectious brain edema [J]. Hunan Yi Ke Da Xue Xue Bao, 2000, 25(6):519ª²521.

[8]CHUNG CP, PARK JB, BAE KH. Pharmacological effects of methanolic extract from the root of Scutellaria baicalensis and its flavonoids on human gingival fibroblast [J]. Planta Med, 1995, 61(2):150ª²153.

[9]YAMADA SD, BALDWIN RL, KARLAN BY. Ovarian carcinoma cell cultures are resistant to TGFª²beta1ª²mediated growth inhibition despite expression of functional receptors [J]. Gynecol Oncol, 1999, 75(1):72ª²77.

[10]LIU D, XU JK, FIGLIOMENI L, et al. Expression of RANKL and OPG mRNA in periodontal disease: possible involvement in bone destruction [J]. Int J Mol Med, 2003, 11(1):17ª²21.

[11]TENG YT, NGUYEN H, GAO X, et al . Functional human Tª²cell immunity and osteoprotegerin ligand control alveolar bone destruction in periodontal infection [J]. J Clin Invest, 2000, 106(6):749ª²752.

[12]VALVERDE P, KAWAI T, TAUBMAN MA. Selective blockade of voltageª²gated potassium channels reduces inflammatory bone resorption in experimental periodontal disease [J]. J Bone Miner Res, 2004, 19(1):155ª²164.

[13]DUMITRESCU AL, ABDª²ELª²ALEEM S, MORALESª²AZA B, et al. A model of periodontitis in the rat: effect of lipopolysaccharide on bone resorption, osteoclast activity, and local peptidergic innervation [J]. J Clin Periodontol, 2004, 31(8):596ª²603.

[14]RAMAMURTHY NS, RIFKIN BR, GREENWALD RA, et al. Inhibition of matrix metalloproteinaseª²mediated periodontal bone loss in rats: a comparison of 6 chemically modified tetracline [J]. J Periodontal, 2002, 73(7):726ª²734.

ÉÏÒ»Ò³  [1] [2] [3] [4] [5] [6] [7]  ÏÂÒ»Ò³